These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1088948)

  • 21. The formulary system: product of the teaching hospital.
    Francke DE
    Hospitals; 1967 Nov; 41(22):110 passim. PubMed ID: 6062395
    [No Abstract]   [Full Text] [Related]  

  • 22. Formulary management to reduce cost: P & T committee strategies.
    Roberts MJ; Summerfield MR
    Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some legal aspects of the hospital formulary system.
    Fink JL
    Am J Hosp Pharm; 1974 Jan; 31(1):86-90. PubMed ID: 4589389
    [No Abstract]   [Full Text] [Related]  

  • 24. Developing a unit-of-use drug distribution system for the hospital emergency room.
    Schiavone JD
    Hosp Pharm; 1981 Apr; 16(4):208-9, 214-5, 219 passim. PubMed ID: 10251101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
    Benner EJ; Mykita L; Brown K
    Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evolution of an effective P & T Committee: advice from the chairman.
    Williams RR
    Hosp Formul; 1986 Dec; 21(12):1232-5, 1243. PubMed ID: 10279772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The foremost problems associated with formulary management.
    Davis NM
    Hosp Pharm; 1983 Mar; 18(3):131, 134-5. PubMed ID: 10260204
    [No Abstract]   [Full Text] [Related]  

  • 28. How to develop a proactive formulary system.
    Crane VS; Gonzalez ER; Hull BL
    Hosp Formul; 1994 Oct; 29(10):700-2, 704-8, 710. PubMed ID: 10137847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reducing the number of formulary theophylline preparations.
    Anandan JV
    Am J Hosp Pharm; 1981 Apr; 38(4):511-3. PubMed ID: 7282676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulary management in an integrated health care system.
    Beis SJ; Anandan JV
    Pharm Pract Manag Q; 1999 Jan; 18(4):43-9. PubMed ID: 10339067
    [No Abstract]   [Full Text] [Related]  

  • 31. ASHP technical assistance bulletin on assessing cost-containment strategies for institutional pharmacies.
    Am J Hosp Pharm; 1985 Jul; 42(7):1583-91. PubMed ID: 4025363
    [No Abstract]   [Full Text] [Related]  

  • 32. Integration of formulary systems with centralized pharmaceutical procurement.
    Smith EB; Hope SM; Halstead SK; Ford WM
    Hosp Formul; 1990 Feb; 25(2):193-6, 198. PubMed ID: 10170504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacy and Therapeutics committee. Cost-containment considerations.
    Hochla PK; Tuason VB
    Arch Intern Med; 1992 Sep; 152(9):1773-5. PubMed ID: 1520043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to crack the $2 billion hospital market for pharmaceuticals.
    Zellmer WA
    Med Mark Media; 1981 May; 16(5):16, 24. PubMed ID: 10251527
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacoeconomic considerations in rural hospitals.
    Lenhert P
    Cost Qual Q J; 1998 Jun; 4(2):37-42. PubMed ID: 10182598
    [No Abstract]   [Full Text] [Related]  

  • 36. What process does your P&T Committee use to obtain staff physicians' input regarding formulary decisions?
    Tompkins GC
    Hosp Formul; 1992 Feb; 27(2):197. PubMed ID: 10116717
    [No Abstract]   [Full Text] [Related]  

  • 37. P & T Committee interview: Establishing and maintaining a dynamic formulary.
    Rostand S; Lazarus H
    Hosp Formul; 1988 Jan; 23(1):48-53. PubMed ID: 10285373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computer-based support system for formulary decisions.
    Senthilkumaran K; Shatz SM; Kalies RF
    Am J Hosp Pharm; 1987 Jun; 44(6):1362-6. PubMed ID: 3618613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Achieving rational therapeutics through consensus-based protocols and follow-up.
    Quintiliani R; Gousse GC; Chow MS
    Hosp Formul; 1990 Mar; 25(3):283-4, 289-94. PubMed ID: 10103836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulary designation of cimetidine as the primary intravenous histamine H2-receptor antagonist.
    Berkowitz HS
    Am J Hosp Pharm; 1992 Jan; 49(1):134-5. PubMed ID: 1349201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.